HA-29

HA-29 is an antiplatelet aggregation agent. HA-29 acts as a cyclooxygenase inhibitor and a thromboxane A2/prostaglandin endoperoxide receptor antagonist. HA-29 exerts its effects by inhibiting cyclooxygenase to block the formation of thromboxane A2 (TXA2), while simultaneously blocking the TXA2/prostaglandin endoperoxide receptor on platelets as a non-competitive antagonist. HA-29 can be used in antithrombotic research.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • CAS. Nr.: 142733-19-5
  • Formel: C16H16N2O3
  • Molecular Weight:284.32
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biologische Aktivität
  • Chemical Information
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs

Alle COX Isoform-spezifische Produkte anzeigen

More

Alle Prostaglandin Receptor Isoform-spezifische Produkte anzeigen

More
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00